Skip to Content

Clinical Trials Details

Astex AT13397-05

Patient Information

Astex AT13397-05 is a Study of HSP90 Inhibitor AT13387 Alone and in Combination with Crizotinib in the Treatment of Non-small Cell Lung Cancer (NSCLC)

Learn more information on clinical trial - Astex AT13397-05.

Study Number
Astex AT13397-05

Clinical Trial Categories

  • Lung Cancer - Metastatic


  • Cone Health Cancer Center
    501 N Elam Ave
    Greensboro, NC 27403-1199
    Main: 336-832-1100
    Fax: 336-832-0794

Also in this Section